ScinoPharm Taiwan Ltd
TWSE:1789
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
TW |
|
P
|
PetroVietnam Power Engineering Consulting JSC
VN:PPE
|
VN |
|
J Resources Asia Pasifik Tbk PT
IDX:PSAB
|
ID |
|
Hyundai Motor Co
KRX:005380
|
KR |
|
A
|
Applied Industrial Technologies Inc
F:AT4
|
US |
|
Eurasia Mining PLC
LSE:EUA
|
UK |
|
S
|
Sunstone Hotel Investors Inc
F:UF2
|
US |
|
S
|
SQD.ai Strategies AG
XMUN:IPOK
|
DE |
|
Lara Exploration Ltd
F:LEW
|
CA |
|
Kuaishou Technology
HKEX:1024
|
CN |
|
Republic Airways Holdings Inc
F:M2A0
|
US |
Intrinsic Value
Is ScinoPharm Taiwan Ltd undervalued or overvalued?
See the intrinsic value estimate for ScinoPharm Taiwan Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ScinoPharm Taiwan Ltd looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ScinoPharm Taiwan Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What ScinoPharm Taiwan Does
ScinoPharm Taiwan makes active pharmaceutical ingredients, or APIs, which are the core drug compounds used by other drugmakers to produce finished medicines. Its business is centered on developing and manufacturing complex small-molecule ingredients, with a particular focus on high-value oncology and other specialty drugs that are difficult to make reliably at scale.
- Headquarters
- Taiwan TW
- IPO date
- Oct 29, 2010
Revenue & Expenses Breakdown
ScinoPharm Taiwan Ltd
Earnings Waterfall
ScinoPharm Taiwan Ltd
The intrinsic value for ScinoPharm Taiwan Ltd (1789) under the Base Case is hidden TWD.
Compared with the current market price of 19.45 TWD, the stock appears hidden.